Contraceptive vaginal rings: Efficacy and acceptability
R. Sitruk-Ware, & C.W. Bardin. New York: Marcel Dekker
Shoupe D., Mishell D.R. Jr. Contraceptive vaginal rings efficacy and acceptability . Sitruk-Ware R., Bardin C.W. Contraception Newer Pharmacological Agents, Devices and Delivery Systems . 1992;71-89 Marcel Dekker, New York.
Acceptability of the contraceptive vaginal ring by rural and urban populations in two Latin American countries
Faundes A., Hardy E., Reyes Q., Pastene L., Portes-Carrasco R. Acceptability of the contraceptive vaginal ring by rural and urban populations in two Latin American countries. Contraception. 24:1981;393-414.
The acceptability of a combined estrogen-progestogen contraceptive vaginal ring
Weisberg E., Fraser I.S., Mishell D.R. Jr, Lacarra M., Bardin C.W. The acceptability of a combined estrogen-progestogen contraceptive vaginal ring. Contraception. 51:1995;39-44.
A contraceptive vaginal ring releasing norethindrone acetate and ethynyl estradiol
Ballagh S.A., Mishell D.R. Jr, Lacarra M., et al. A contraceptive vaginal ring releasing norethindrone acetate and ethynyl estradiol. Contraception. 50:1994;517-533.
Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol: Ovarian function, bleeding control and lipoprotein patterns
Victor A., Lithell H., Selenius I., Vessby B. Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol ovarian function, bleeding control and lipoprotein patterns . Contraception. 31:1985;131-139.
Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol
Ballagh S.A., Mishell D.R. Jr, Jackanicz T.M., Lacarra M., Eggins P. Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol. Contraception. 50:1994;535-549.
Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring
Weisberg E., Fraser I.S., Lacarra M., Mishell D.R. Jr, Jackanicz T. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring. Contraception. 56:1997;233-240.
Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring
Bounds W., Szarewski A., Lowe D., Guillebaud J. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring. Eur J Obstet Gynecol Reprod Biol. 48:1993;123-125.
Hormonal effects of the 300 μg norethisterone minipill. 1: Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration
Landgren B.-M., Diczfalusy E. Hormonal effects of the 300 μg norethisterone minipill. 1 Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration . Contraception. 23:1980;585-605.
Variations in vaginal mucosal surface appearance determined by colposcopic inspection in healthy, sexually-active women
in press
Fraser IS, Lahteenmaki P, Lacarra M, et al. Variations in vaginal mucosal surface appearance determined by colposcopic inspection in healthy, sexually-active women. Human Reprod; 1999, in press.
Vaginal mucosal surface appearances in women using vaginal rings for contraception
submitted for publication
Fraser IS, Lacarra M, Mishell DR Jr, et al. Vaginal mucosal surface appearances in women using vaginal rings for contraception. Contraception; submitted for publication.
